김평화 교수 연구실
article|
인용수 1
·2025
Prognostic Value of POST-Treatment Extent of Tumor (POSTTEXT) System in Patients with Hepatoblastoma
Ho Joong Jeong, Hee Mang Yoon, Pyeong Hwa Kim, Ah Young Jung, Young Ah Cho, Jin Seong Lee, Kyung‐Nam Koh, Jung‐Man Namgoong
IF 3.8Cancer Research and Treatment
초록
Predictors of EFS in hepatoblastoma include AFP levels after the fourth cycle of neoadjuvant chemotherapy, tumor size change ratio, and metastasis (POSTTEXT M). Combining AFP levels after the fourth cycle of neoadjuvant chemotherapy to the CHIC-HS improved the predictive ability.
키워드
HepatoblastomaMedicineChemotherapyInternal medicineOncologyConcomitantProportional hazards modelMedical recordReceiver operating characteristicRetrospective cohort study